Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) FCF Payout Ratio (2016 - 2025)

Utah Medical Products has reported FCF Payout Ratio over the past 16 years, most recently at 0.29 for Q4 2025.

  • Quarterly results put FCF Payout Ratio at 0.29 for Q4 2025, down 18.17% from a year ago — trailing twelve months through Dec 2025 was 0.28 (down 4.67% YoY), and the annual figure for FY2025 was 0.28, down 4.67%.
  • FCF Payout Ratio for Q4 2025 was 0.29 at Utah Medical Products, up from 0.26 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for UTMD hit a ceiling of 1.76 in Q4 2021 and a floor of 0.16 in Q1 2023.
  • Median FCF Payout Ratio over the past 5 years was 0.23 (2021), compared with a mean of 0.32.
  • Biggest five-year swings in FCF Payout Ratio: surged 890.68% in 2021 and later tumbled 89.44% in 2022.
  • Utah Medical Products' FCF Payout Ratio stood at 1.76 in 2021, then tumbled by 89.44% to 0.19 in 2022, then rose by 9.68% to 0.2 in 2023, then skyrocketed by 73.51% to 0.35 in 2024, then dropped by 18.17% to 0.29 in 2025.
  • The last three reported values for FCF Payout Ratio were 0.29 (Q4 2025), 0.26 (Q3 2025), and 0.35 (Q2 2025) per Business Quant data.